NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Integrated Biosciences

Integrated Biosciences

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://integratedbiosciences.com/

Last Round

Seed

Oct 3, 2024

Total Funding Raised

$17.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Integrated Biosciences is a biotechnology company that develops next-generation therapeutics for age-related diseases by combining synthetic biology, artificial intelligence, and optogenetics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoveryAI drug discoverylongevity biotechlongevity therapeuticscellular senescencesmall moleculesynthetic biologygerosciencede novo designcomputational biologyAI-driven biotechage-related diseasedrug pipelinebiotech platformprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Integrated Biosciences Comparables

Compare Integrated Biosciences with similar companies based on industry and business-model similarity.

Integrated Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gero
81%
Rubedo Life Sciences
81%
Transcripta Bio
81%

Integrated Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 3, 2024

Integrated Biosciences Investors

Notable investors and investment history

Integrated Biosciences investors
InvestorRounds
PolymathSeed
Root VenturesSeed
Illumina Ventures LabsSeed
SH FundSeed
Conscience VCSeed
Mission BioCapitalSeed
LifeSpan Vision VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Tony Wu, Co-Founder of xAI, joins the board.

  • Jan 27, 2026

    Daniel J. Anderson appointed as the new Chief Scientific Officer.

Integrated Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Integrated Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Integrated Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range17
Year Founded2022
Last FundingOct 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.